Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tadalafil and Tamsulosin for BPH in Asian Men
NCT00540124Phase 2Completed
- Sponsor
- Eli Lilly and Company
- Start
- Oct 2007
- Primary completion
- Jun 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of tadalafil in benign prostatic hyperplasia (BPH), sponsored by Eli Lilly and Company. Primary endpoint: International Prostate Symptom Score Total Score at 12 weeks. Started Oct 2007; status: completed.
02
Drugs
tadalafil
03
Conditions
benign prostatic hyperplasia (BPH)
Beyond the preview
Go deeper on NCT00540124.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00540124.